Irritable bowel syndrome with diarrhea
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meet IBS-D diagnostic criteria; (2) Age 18-65 years; (3) A total IBS-SSS score of =75 at baseline; (4) Had not used any medication for IBS for at least 2 weeks before treatment and had not received acupuncture for IBS-D in the last 3 months; (5) Voluntarily participated in the study by signing an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Those with organic lesions of the intestinal tract, or systemic diseases that affect the function of the digestive tract; (2) Those who have a combination of serious primary diseases such as cardiovascular system, liver, kidney, hematopoietic system, psychiatric disorders, and significant cognitive dysfunction; (3) Those with a history of abdominal or rectal-anal surgery; (4) Pregnant, lactating, postpartum women = 12 months and those with allergies; (5) Those with metal allergy or severe fear of needles; (6) Participating in other clinical trials, which will affect the observation of efficacy indicators; (7) Those who refuse to sign the informed consent and violate the trial program. Note: Anyone with any of the above conditions should be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IBS Symptom Severity Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| IBS Specialized Quality of Life Scale;Bristol Fecal Characterization Scale; | — |
Countries
China
Contacts
Affiliated Hospital of Jiangxi University of Chinese Medicine